Emanzen DP Tablet is a combination of three medicines: Diclofenac, Paracetamol / Acetaminophen and Serratiopeptidase which relieve pain. Diclofenac is a non-steroidal antiinflammatory drug (NSAID) and Paracetamol / Acetaminophen is an antipyretic (fever reducer). They work by blocking the release of certain chemical messengers in the brain that cause pain and fever. Serratiopeptidase is an enzyme which works by breaking down abnormal proteins at the site of inflammation, and promotes healing.
Taking Diclofenac+Paracetamol / Acetaminophen+Serratiopeptidase with alcohol can cause liver damage.
WEIGH RISKS VS BENEFITS
Emanzen DP Tablet is unsafe to use during pregnancy. There is positive evidence of human fetal risk, but the benefits from use in pregnant women may be acceptable despite the risk, for example in life-threatening situations. Please consult your doctor.
No information is available on the use of Emanzen DP Tablet during lactation. Please consult your doctor.
Do not drive unless you are feeling well. Emanzen DP Tablet may cause headaches, blurred vision, dizziness or drowsiness in some patients. This may affect your ability to drive.
Emanzen DP Tablet should be used with caution in patients with kidney disease. Dose adjustment of Emanzen DP Tablet may be needed. Please consult your doctor.
Emanzen DP Tablet should be used with caution in patients with liver disease. Dose adjustment of Emanzen DP Tablet may be needed. Please consult your doctor. However, the use of Emanzen DP Tablet is not recommended in patients with severe liver disease and active liver disease.
What were the side-effects while using Emanzen DP Tablet?
How much was the improvement?
What are you using Emanzen DP Tablet for?
Survey Participants: 6
“The following are the results of on-going survey on 1mg.com for Emanzen DP Tablet. These results only indicate the perceptions of the website users. Please base your medical decisions only on the advice of a doctor or a registered medical professional.”
Information last updated by Dr. Varun Gupta, MD Pharmacology on 25th Jan 2018.